Results 91 to 100 of about 859,888 (229)
JACC Case ReportsMitral and tricuspid regurgitation, linked to high morbidity and mortality, are increasingly treated with interventional edge-to-edge repair, showing excellent results in favorable anatomy.
V. Dannenberg +3 more
semanticscholar +1 more source
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT Introduction Transvenous pacemakers are effective but carry significant short‐ and long‐term complications. Leadless pacemakers were developed to overcome these limitations, however, data in high‐risk patients ineligible for transvenous systems remain limited.
Moshe Katz +7 more
wiley +1 more source
Case report of a transcatheter tricuspid valve-in-valve replacement [PDF]
Transcatheter valve implantations in the tricuspid position are infrequent. We report a case of an Edwards SAPIEN 3 (S3) implantation in the tricuspid position as a transcatheter valve-in-valve procedure in a 12-year-old patient deemed at high risk for ...
Pillay, DN, Brown, SC, Buys, DG
core +1 more source
Reviews in Cardiovascular Medicine, 2023 Tricuspid regurgitation (TR) may occur late after left-sided valve surgery (LSVS). Isolated tricuspid regurgitation after left-sided valve surgery (iTR-LSVS) refers to isolated TR without significant lesions in the mitral and/or aortic position late ...
Jinmiao Chen +28 more
doaj +1 more source
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT Atrioventricular conduction disturbances and the need for cardiac implantable electronic device (CIED) therapy are frequently required after transcatheter tricuspid valve implantation (TTVI). The interaction between the annulus, transcatheter heart valve and the leads is often complex and the optimal management under debate.
Thomas Seiler +9 more
wiley +1 more source
Frontiers in Cardiovascular Medicine, 2023 The tricuspid valve is a complex structure with normal function dependent on the leaflet morphology, right atrial and annular dynamics, and right ventricular and chordal support. Thus, the pathophysiology of tricuspid regurgitation (TR) is equally complex and current medical and surgical management options are limited.
David I. Blusztein, Rebecca T. Hahn
openaire +3 more sources
Dyssynchrony without dysfunction: Left bundle branch block does not acutely reduce cardiac output
The Journal of Physiology, EarlyView.Abstract figure legend Six electromechanical in silico heart models were simulated under healthy and pure acute left bundle branch block (LBBB) conditions. LBBB induced electrical dyssynchrony and increased left ventricular free wall strain, while the right and left ventricular ejection fraction remained relatively unchanged.
Carola Kruthoff +6 more
wiley +1 more source
Role of computed tomography in transcatheter coronary and structural heart disease interventions
REC: Interventional Cardiology (English Ed.)Computed tomography is a noninvasive imaging technique with high spatial resolution, providing excellent definition of calcium and intravascular space through the use of contrast media.
Manuel Barreiro-Pérez +9 more
doaj +1 more source
Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery
Catheterization and Cardiovascular Interventions, Volume 108, Issue 5, Page 1962-1964, November 1, 2026.ABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Seyed Hossein Aalaei‐Andabili +2 more
wiley +1 more source
Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
Catheterization and Cardiovascular Interventions, Volume 108, Issue 4, Page 1380-1385, October 1, 2026.ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß +14 more
wiley +1 more source